0001377053-14-000003.txt : 20140916
0001377053-14-000003.hdr.sgml : 20140916
20140916121256
ACCESSION NUMBER: 0001377053-14-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20140916
DATE AS OF CHANGE: 20140916
EFFECTIVENESS DATE: 20140916
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AtheroNova Inc.
CENTRAL INDEX KEY: 0001377053
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201915083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-224793
FILM NUMBER: 141104907
BUSINESS ADDRESS:
STREET 1: 2301 DUPONT DRIVE, SUITE 525
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (949) 525-5471
MAIL ADDRESS:
STREET 1: 2301 DUPONT DRIVE, SUITE 525
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: AtheroNova, Inc.
DATE OF NAME CHANGE: 20100519
FORMER COMPANY:
FORMER CONFORMED NAME: Trist Holdings, Inc.
DATE OF NAME CHANGE: 20080103
FORMER COMPANY:
FORMER CONFORMED NAME: LandBank Group Inc
DATE OF NAME CHANGE: 20061002
D
1
primary_doc.xml
X0707
D
LIVE
0001377053
AtheroNova Inc.
2301 DUPONT DRIVE, SUITE 525
IRVINE
CA
CALIFORNIA
92612
(949) 525-5471
DELAWARE
AtheroNova, Inc.
Trist Holdings, Inc.
LandBank Group Inc
Corporation
true
Mark
Selawski
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Executive Officer
Thomas
W
Gardner
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Executive Officer
Director
Gary
Freeman
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Paul
DiPerna
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Boris
Ratiner
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Chaim
Davis
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Alexander
Polinsky
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Fred
Knoll
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Johan
M
Spoor
2301 Dupont Drive, Suite 525
Irvine
CA
CALIFORNIA
92612
Director
Pharmaceuticals
Decline to Disclose
- 06c
false
2014-09-12
false
true
true
true
false
0
1000000
500000
500000
false
7
0
0
0
false
AtheroNova Inc.
/s/ Mark Selawski
Mark Selawski
Chief Financial Officer
2014-09-16